NBTX logo

Nanobiotix SA (NBTX)

Profile

Full Name

Nanobiotix S.A.

Ticker Symbol

NBTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

France

IPO

December 11, 2020

Indexes

Not included

Website

http://www.nanobiotix.com

Employees

108

Key Details

Price

$3.33(-0.06%)

Market cap

$157.86M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-$12.56M(-138.61% YoY)

Annual EPS

-$1.56(-33.30% YoY)

PE ratio

-

Next earnings date

May 22, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.33
NBTX price is $3.33

30-Day Relative Volume

0.08
NBTX 30-day relative volume is 0.08

Price Performance

Price Most recent change

-0.06%
NBTX price was down -0.06% on Apr 14, 2025

Price YTD change

+16.03%
NBTX price is up +16.03% since January 1st

Price 1-year change

-45.32%
NBTX price is down -45.32% year-on-year

Price 3-year change

-48.77%
NBTX price is down -48.77% over the past 3 years

Price Range

Price All-time high

$21.55
NBTX price is currently -84.55% below its historical high of $21.55

Price 3-year low

$1.75
NBTX price is currently +90.29% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$157.86M
NBTX market capitalization is $157.86 million

Market cap 3-year change

-30.37%
NBTX market capitalization is down -30.37% over the past 3 years

Market cap All-time high

$677.37M
NBTX market capitalization is currently -76.70% below its historical high of $677.37 million

Market cap sector rank

54.31%
NBTX market capitalization is higher than 54.31% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.62%
NBTX shares outstanding is up +0.62% year-on-year

Shares Outstanding 3-Year Change

+35.92%
NBTX shares outstanding is up +35.92% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.64
NBTX beta is 0.64

200-day SMA

$4.20
NBTX price is currently -20.72% below its 200-day simple moving average

50-day SMA

$3.55
NBTX price is currently -6.12% below its 50-day simple moving average

RSI

47.45
NBTX 14-day relative strength index is 47.45

Volume

0.08
NBTX 30-day relative volume is 0.08

ATR

$0.20
NBTX average true range is $0.20

10-day Historical Volatility

55.98%
NBTX 10-day historical volatility is 55.98%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-$12.56M
NBTX annual revenue is -$12.56 million

Revenue Analysts estimate

$18.95M
NBTX annual revenue is currently -166.31% lower than the consensus analysts' forecast

Revenue 1-year change

-138.61%
NBTX annual revenue is down -138.61% year-on-year

Revenue Sector rank

0.11%
NBTX annual revenue is higher than 0.11% of companies in Healthcare sector

EPS

EPS

-$1.56
NBTX annual earnings per share is -$1.56

EPS Analysts estimate

-$0.69
NBTX annual earnings per share is currently +125.04% higher than the consensus analysts' forecast

EPS 1-year change

-33.3%
NBTX annual earnings per share is down -33.3% year-on-year

EPS Sector rank

44.59%
NBTX annual earnings per share is higher than 44.59% of companies in Healthcare sector

Profit

Gross profit

-
NBTX annual gross profit value is unknown

Gross margin

-
NBTX annual gross profit margin value is unknown

Operating profit

-$74.02M
NBTX annual operating income is -$74.02 million

Operating margin

-
NBTX annual operating profit margin value is unknown

Net income

-$73.74M
NBTX annual net profit is -$73.74 million

Net margin

-
NBTX annual net profit margin value is unknown

Expenses

Total expenses

$61.46M
NBTX annual total expenses is $61.46 million

Operating expenses

$61.46M
NBTX annual total operating expenses is $61.46 million

Cost of goods sold

-
NBTX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$21.71M
NBTX annual SGA is $21.71 million

Depreciation and amortization

$1.75M
NBTX annual depreciation & amortization is $1.75 million

Interest expense

$8.75M
NBTX annual interest expense is $8.75 million

Income tax

$109.30K
NBTX annual income tax is $109.30 thousand

EBIT & EBITDA

EBIT

-$64.88M
NBTX annual earnings before interest & taxes is -$64.88 million

EBITDA

-$63.13M
NBTX annual EBITDA is -$63.13 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$70.15M
NBTX annual total assets is $70.15 million

Non current assets

$6.19M
NBTX annual long term assets is $6.19 million

Current assets

$63.96M
NBTX annual total current assets is $63.96 million

Cash and cash equivalents

$51.75M
NBTX annual cash & cash equivalents is $51.75 million

Accounts receivable

$3.10M
NBTX annual accounts receivable is $3.10 million

Inventory

-
NBTX annual inventory value is unknown

Liabilities

Total liabilities

$138.52M
NBTX annual total liabilities is $138.52 million

Long term liabilities

$77.20M
NBTX annual total long term liabilities is $77.20 million

Current liabilities

$61.33M
NBTX annual total current liabilities is $61.33 million

Accounts payable

$4.67M
NBTX annual accounts payable is $4.67 million

Debt

Total debt

$52.97M
NBTX annual total debt is $52.97 million

Total debt 1-year change

-5.24%
NBTX annual total debt is down -5.24% year-on-year

Long term debt

$47.84M
NBTX annual long term debt is $47.84 million

Short term debt

$5.12M
NBTX annual short term debt is $5.12 million

Equity & Capital

Shareholders equity

-$68.37M
NBTX annual stockholders equity is -$68.37 million

Book value

-$68.37M
NBTX annual book value is -$68.37 million

Retained earnings

-$70.90M
NBTX annual retained earnings is -$70.90 million

Working capital

$2.63M
NBTX annual working capital is $2.63 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$21.16M
NBTX annual cash flow from operations is -$21.16 million

Cash from operations 1-year change

-56.67%
NBTX annual cash flow from operations is down -56.67% year-on-year

Cash from investing

-$1.03M
NBTX annual cash flow from investing activities is -$1.03 million

Cash from investing 1-year change

-173.58%
NBTX annual cash flow from investing activities is down -173.58% year-on-year

Cash from financing

-$5.56M
NBTX annual cash flow from financing activities is -$5.56 million

Cash from financing 1-year change

-110.98%
NBTX annual cash flow from financing activities is down -110.98% year-on-year

CAPEX

CAPEX

$917.80K
NBTX annual capital expenditures is $917.80 thousand

CAPEX 1-year change

+151.59%
NBTX annual capital expenditures is up +151.59% year-on-year

Free Cash Flow

Free cash flow

-$22.08M
NBTX annual free cash flow is -$22.08 million

Free cash flow 1-year change

-59.17%
NBTX annual free cash flow is down -59.17% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
NBTX annual gross profit margin value is unknown

Operating margin

-
NBTX annual operating profit margin value is unknown

Net margin

-
NBTX annual net profit margin value is unknown

ROA & ROE

ROA

-84.79%
NBTX annual return on assets is -84.79%

ROE

107.86%
NBTX annual return on equity is 107.86%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NBTX price to earnings ratio value is unknown

PE ratio Sector rank

-
NBTX price to earnings ratio is unknown

PB Ratio

PB ratio

-2.31
NBTX price to book ratio is -2.31

PB ratio Sector rank

5.59%
NBTX price to book ratio is higher than 5.59% of companies in Healthcare sector

PS Ratio

PS ratio

-
NBTX price to sales ratio value is unknown

PS ratio Sector rank

-
NBTX price to sales ratio is unknown

Enterprise value

Enterprise value

$159.07M
NBTX enterprise value is $159.07 million

Enterprise value Sector rank

55.49%
NBTX enterprise value is higher than 55.49% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
NBTX EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
NBTX EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.04
NBTX annual current ratio is 1.04

Quick ratio

-
NBTX annual quick ratio value is unknown

Leverage

Debt to equity

-0.71
NBTX annual debt to equity ratio is -0.71

Interest coverage ratio

-7.41
NBTX annual interest coverage ratio is -7.41

Risk & Stability

Piotroski F-Score

-
NBTX piotroski f-score value is unknown

Altman Z-Score

-3.92
NBTX altman z-score is -3.92

Analyst ratings

Recent major analysts updates

Apr 4, 25 Guggenheim
Buy
Aug 28, 24 Guggenheim
Buy
Dec 8, 23 Leerink Partners
Outperform
Jan 6, 21 Evercore ISI Group
Outperform

Institutional Ownership

Similar stocks

FULC logo
Fulcrum Therapeutics (FULC)
BWAY logo
BrainsWay (BWAY)
Actuate Therapeutics (ACTU)
MASS logo
908 Devices (MASS)
JYNT logo
Joint (JYNT)
RZLT logo
Rezolute (RZLT)
ARAY logo
Accuray Incorporated (ARAY)
Aardvark Therapeutics (AARD)
CGC logo
Canopy Growth (CGC)
  • What is the ticker symbol for Nanobiotix SA?
  • Does Nanobiotix SA pay dividends?
  • What sector is Nanobiotix SA in?
  • What industry is Nanobiotix SA in?
  • What country is Nanobiotix SA based in?
  • When did Nanobiotix SA go public?
  • Is Nanobiotix SA in the S&P 500?
  • Is Nanobiotix SA in the NASDAQ 100?
  • Is Nanobiotix SA in the Dow Jones?
  • When was Nanobiotix SA's last earnings report?
  • When does Nanobiotix SA report earnings?

What is the ticker symbol for Nanobiotix SA?

The ticker symbol for Nanobiotix SA is NASDAQ:NBTX

Does Nanobiotix SA pay dividends?

No, Nanobiotix SA does not pay dividends

What sector is Nanobiotix SA in?

Nanobiotix SA is in the Healthcare sector

What industry is Nanobiotix SA in?

Nanobiotix SA is in the Biotechnology industry

What country is Nanobiotix SA based in?

Nanobiotix SA is headquartered in France

When did Nanobiotix SA go public?

Nanobiotix SA's initial public offering (IPO) was on December 11, 2020

Is Nanobiotix SA in the S&P 500?

No, Nanobiotix SA is not included in the S&P 500 index

Is Nanobiotix SA in the NASDAQ 100?

No, Nanobiotix SA is not included in the NASDAQ 100 index

Is Nanobiotix SA in the Dow Jones?

No, Nanobiotix SA is not included in the Dow Jones index

When was Nanobiotix SA's last earnings report?

Nanobiotix SA's most recent earnings report was on Apr 2, 2025

When does Nanobiotix SA report earnings?

The next expected earnings date for Nanobiotix SA is May 22, 2025
On this page